Showing results (51-60 of 3,094) with videos related to
Sort By:
Pageof 310
Expert Review of Anticancer Therapy|October 15, 2020
Metronomic therapy in advanced breast cancer and NSCLC: vinorelbine as a paradigm of recent progressBinghe Xu, Tao Sun, Shusen Wang, et al.Expert Review of Anticancer Therapy|November 21, 2022
The evolving therapeutic landscape of antibody-drug conjugates in breast cancerNan Chen, Elena Michaels, Frederick Howard, et al.Expert Review of Anticancer Therapy|May 6, 2022
Early detection of hepatocellular carcinoma: roadmap for improvementJonathan Melendez-Torres, Amit G SingalExpert Review of Anticancer Therapy|June 23, 2022
The current treatment approach to adolescents and young adults with acute lymphoblastic leukemia (AYA-ALL): challenges and considerationsHasmukh Jain, Akhil Rajendra, Manju Sengar, et al.Expert Review of Anticancer Therapy|June 10, 2021
The mechanisms of resistance to second- and third-generation ALK inhibitors and strategies to overcome such resistanceNaoki Haratake, Gouji Toyokawa, Takashi Seto, et al.Expert Review of Anticancer Therapy|January 13, 2021
Adopting an alternative structure for clinical trials in immunotherapyEvanthia T Roussos Torres, Alan L EpsteinExpert Review of Anticancer Therapy|September 23, 2016
Optimum treatment for mediastinal lymph node positive (N2) resectable non-small cell lung cancer: what is the role for surgery?Musaddiq Awan, Neelesh Sharma, Christopher W Towe, et al.Expert Review of Anticancer Therapy|June 10, 2017
MUC1 induces tamoxifen resistance in estrogen receptor-positive breast cancerParnaz Merikhian, Reyhane Ghadirian, Leila Farahmand, et al.Expert Review of Anticancer Therapy|June 13, 2017
Checkpoint inhibitors in advanced melanoma: effect on the field of immunotherapyAine O'reilly, James LarkinExpert Review of Anticancer Therapy|June 14, 2017
Limiting the morbidity of inguinofemoral lymphadenectomy in vulvar cancer patients; a reviewAnne-Floor W Pouwer, Henriette J Arts, Jacobus van der Velden, et al.Pageof 310